APLN and melanoma: PrognoScan database analyzed a patient cohort of 38 samples based on the HG-U133_Plus_2 microarray data, and also suggested that high expression levels of apelin gene are potential negative prognosticators in patients with melanoma (the corrected p value = 0.0405; Supp Fig. 3B)55.